Showing results (111-120 of 890) with videos related to

Sort By:
Pageof 89
Congestive Heart Failure (Greenwich, Conn.)|August 16, 2012
Natriuretic peptide testing for predicting adverse events following heart failure hospitalizationJames L Januzzi, Alan S Maisel, Marc Silver, et al.
American Journal of Clinical Pathology|July 17, 2008
Inflammatory markers, amino-terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patientsShafiq Rehman, Donald M Lloyd-Jones, Abelardo Martinez-Rumayor, et al.
Circulation. Heart Failure|September 2, 2016
Established and Emerging Roles of Biomarkers in Heart Failure Clinical TrialsNasrien E Ibrahim, Hanna K Gaggin, Marvin A Konstam, et al.
Reviews in Cardiovascular Medicine|February 25, 2017
Advances in Heart Failure Management: Improving Outcomes With InnovationNasrien E Ibrahim, Akshay S Desai, Jagmeet P Singh, et al.
Pathology, Research and Practice|September 20, 2022
Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profilesHan-Na Kim, Soomin Ahn, Kyoung-Mee Kim
International Journal of Dental Hygiene|April 12, 2026
Histogram-Corrected Intraoral Photographs for Early Gingivitis Screening in Orthodontic PatientsJi-Youn Kim, Kyuseok Kim, Han-Na Kim
The American Journal of Cardiology|July 7, 2009
Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic strokeJesper K Jensen, Dan Atar, Søren R Kristensen, et al.
The American Journal of Cardiology|September 5, 2006
Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency departmentUwe Siebert, James L Januzzi, Molly T Beinfeld, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular diseaseChristopher M Celano, Laura Suarez, Carol Mastromauro, et al.
Circulation. Heart Failure|October 12, 2013
Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failureHanna K Gaggin, Shweta Motiwala, Anju Bhardwaj, et al.
Pageof 89